glp-1 news today Why drugs are changing the future of metabolic health Eli Lilly CEO launches Medicare

Description

[DOI] [PMC free article] [PubMed] [Google Scholar] 30.McGowan B.M., Bruun J.M., Capehorn M., Pedersen S.D., Pietilainen K.H., Muniraju H.A.K., Quiroga M., Varbo A., Lau D.C.W., Group S.S

This economic barrier, combined with injection-related concerns, may limit widespread usage

But Pfizer seems to have concluded that the toxicity question mark would damage its ability to compete in a relatively crowded space

Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study

In addition to helping with weight loss, GLP-1s have been shown to support better overall wellness, including improved blood sugar control, lower risk of heart and kidney disease and relief from joint or sleep-related issues caused by excess weight